Active Ingredient: SODIUM BENZOATE; SODIUM PHENYLACETATE
Proprietary Name: AMMONUL
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10%;10% (5GM/50ML;5GM/50ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N020645
Product Number: 001
Approval Date: Feb 17, 2005
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
